Clinical Trials Directory

Trials / Completed

CompletedNCT04828863

Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

Maple Syrup Urine Disease (MSUD) is a disorder of protein metabolism that leads to neurological differences. It is an exciting time where people diagnosed with MSUD are living longer. The investigators want to learn about how adults with MSUD think, feel, and live. The purpose of this research study is to 1) look at thinking skills, behavior skills, life skills, and quality of life in adults with MSUD and 2) measure how medical and personal factors impact these areas. The results of the study will be used to learn how to best help adults with MSUD and how to prepare for their success. In this study, the participants will answer questions on thinking, life skills, behavior skills, and quality of life. These questions will be completed on the internet. The participants will have a formal testing of their thinking and behavior completed virtually. The participants may also have a 1-2-hour telephone conversation about their life. All tests will occur virtually at home. The investigators will send the participants a letter with the results of thinking and behavior tests.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeurocognitive testingParticipants will undergo a battery of neurocognitive tests that examine intellectual, executive, and adaptive function. The tests will be given remotely via internet-based surveys.

Timeline

Start date
2021-06-12
Primary completion
2023-06-30
Completion
2023-11-30
First posted
2021-04-02
Last updated
2024-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04828863. Inclusion in this directory is not an endorsement.